A California federal judge has determined that biotech company Biogen owes Roche's Genentech more than $88 million in patent ...
A top boarding school has been ordered to pay £145,000 to a pupil who suffered a drug-induced breakdown after she was given ...
WASHINGTON — An experimental medication made from marijuana successfully reduced back pain in a new study, offering further ...
Family members of those who have died from taking the ‘horrific’ Class B are among those calling for it to be reclassified ...
Venezuela is not one of America’s main illicit drug suppliers. Venezuela accounts for very little of the cocaine that enters ...
MedPage Today on MSN
Novel Drug Shows Hints of Promise for Progressive MS
Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
A Craighead County man arrested on a drug charge in 2024 that carries a maximum penalty of 20 years in prison pleaded guilty ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative ...
2don MSN
Diabetes drug and antihistamine could together repair multiple sclerosis damage, trial finds
A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...
Affiliated with the UB Institute for Artificial Intelligence and Data Science, the lab allows Ramanathan and his ...
Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...
News-Medical.Net on MSN
Researchers develop tool to predict how patients will respond to common multiple sclerosis drug
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results